Binder Phenotype—Prenatal Diagnosis, Management, and Postnatal Outcome: Insights from a Case Series and Updated Review of the Literature

Abstract

Binder phenotype (BP) or maxillonasal dysplasia is a developmental disorder of the anterior part of the maxilla and nasal complex and is characterized by a short nose with a flat nasal bridge, short columella, acute nasolabial angle, perialar flatness, convex upper lip, and tendency to a class III malocclusion. The etiology of BP is heterogeneous with diverse features and outcomes. The ultrasound features of BP are midfacial hypoplasia with verticalized nasal bones, short columella with flattened tip and alar wings, and the nasofrontal angle measuring >140 degrees. In this case series, we present seven cases of BP detected antenatally, their varied etiology, management, and outcomes with a 2-year follow-up. We conclude that the diagnosis of facial dysmorphisms, such as BP, brings a lot of apprehension and agony in the parents amounting to multiple tests and counseling sessions. Physiognomy which is the normal familial appearance should be considered before concluding whether the observed feature is normal or pathological. Accurate diagnosis, adequate testing, and personalized counseling will help in the prevention of needless termination of pregnancies and ensure an optimal perinatal outcome.

Keywords

Binder phenotype - Binder syndrome - maxillonasal hypoplasia - midfacial hypoplasia - nasofrontal angle - facial dysmorphism

Publikationsverlauf

Artikel online veröffentlicht:
16. April 2024

• References

• 1 Zuckerlandl E. Fossae paranasales: normale und pathologische. Anat. Nasenhole 1882; 1: 48
• 2 Noyes FB. Case report. Angle Orthod 1939; 9: 160
• 3 Von Binder KH. Dysostosis maxillo-nasalis, ein arhinencephaler Missbildungskomplex. Deutsche Zahnaerztl Z 1962; 17: 438-444
• 4 Cook K, Prefumo F, Presti F, Homfray T, Campbell S. The prenatal diagnosis of Binder syndrome before 24 weeks of gestation: case report. Ultrasound Obstet Gynecol 2000; 16 (06) 578-581
• 5 Oztürk H, İpek A, Tan S. et al. Evaluation of fetal nasofrontal angle in the second trimester in normal pregnancies. J Clin Ultrasound 2011; 39 (01) 18-20
• 6 Keppler-Noreuil KM, Wenzel TJ. Binder phenotype: associated findings and etiologic mechanisms. J Craniofac Surg 2010; 21 (05) 1339-1345
• 7 Howe AM, Webster WS, Vitamin K. Vitamin K–its essential role in craniofacial development. A review of the literature regarding vitamin K and craniofacial development. Aust Dent J 1994; 39 (02) 88-92
• 8 Howe AM, Webster WS. The warfarin embryopathy: a rat model showing maxillonasal hypoplasia and other skeletal disturbances. Teratology 1992; 46 (04) 379-390
• 9 Price PA, Williamson MK, Haba T, Dell RB, Jee WS. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc Natl Acad Sci U S A 1982; 79 (24) 7734-7738
• 10 Pearson DA. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract 2007; 22 (05) 517-544
• 11 Blask AR, Rubio EI, Chapman KA, Lawrence AK, Bulas DI. Severe nasomaxillary hypoplasia (Binder phenotype) on prenatal US/MRI: an important marker for the prenatal diagnosis of chondrodysplasia punctata. Pediatr Radiol 2018; 48 (07) 979-991
• 12 Mazzone E, Cos Sanchez T, Persico N, Cannie MM, Jani J. Binder syndrome: a phenotype rather than a definitive diagnosis?. Ultrasound Obstet Gynecol 2019; 53 (01) 131-132
• 13 Sheffield LJ, Halliday JL, Jensen F. Maxillonasal dysplasia (Binder's syndrome) and chondrodysplasia punctata. J Med Genet 1991; 28 (07) 503-504
• 14 Howe AM, Webster WS, Lipson AH, Halliday JL, Sheffield LJ. Binder's syndrome due to prenatal vitamin K deficiency: a theory of pathogenesis. Aust Dent J 1992; 37 (06) 453-460
• 15 Olow-Nordenram MA, Rådberg CT. Maxillo-nasal dysplasia (Binder syndrome) and associated malformations of the cervical spine. Acta Radiol Diagn (Stockh) 1984; 25 (05) 353-360
• 16 Olow-Nordenram M, Valentin J. An etiologic study of maxillonasal dysplasia–Binder's syndrome. Scand J Dent Res 1988; 96 (01) 69-74
• 17 Gross-Kieselstein E, Har-Even Y, Navon P, Branski D. Familial variant of maxillonasal dysplasia?. J Craniofac Genet Dev Biol 1986; 6 (03) 331-334
• 18 Roy-Doray B, Geraudel A, Alembik Y, Stoll C. Binder syndrome in a mother and her son. Genet Couns 1997; 8 (03) 227-233
• 19 Gorlin J, Cohen M, Levin L. Syndromes of the Head and Neck. Oxford:: Oxford Press; 1990
• 20 McCollum AG, Wolford LM. Binder syndrome: literature review and long-term follow-up on two cases. Int J Adult Orthodon Orthognath Surg 1998; 13 (01) 45-58
• 21 Holmes AD, Lee SJ, Greensmith A, Heggie A, Meara JG. Nasal reconstruction for maxillonasal dysplasia. J Craniofac Surg 2010; 21 (02) 543-551
• 22 Levaillant JM, Moeglin D, Zouiten K. et al. Binder phenotype: clinical and etiological heterogeneity of the so-called Binder maxillonasal dysplasia in prenatally diagnosed cases, and review of the literature. Prenat Diagn 2009; 29 (02) 140-150
• 23 Quarrell OW, Koch M, Hughes HE. Maxillonasal dysplasia (Binder's syndrome). J Med Genet 1990; 27 (06) 384-387